{
    "organizations": [],
    "uuid": "021250c7b399305f2c8e776f0408d44acd32082a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-teva-canada-announces-launch-of-ge/brief-teva-canada-announces-launch-of-generic-concerta-for-treatment-of-adhd-idUSASC09TBJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Teva Canada Announces Launch Of Generic Concerta For Treatment Of ADHD",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 22, 2018 / 12:23 PM / Updated 8 minutes ago BRIEF-Teva Canada Announces Launch Of Generic Concerta For Treatment Of ADHD Reuters Staff March 22 (Reuters) - Teva Pharmaceutical Industries Ltd: * ACT METHYLPHENIDATE ER® TABLETS, A GENERIC VERSION OF CONCERTA® FOR THE TREATMENT OF ADHD * TEVA CANADA LIMITED SAYS HEALTH CANADA APPROVED ITS APPLICATION FOR (C)ACT METHYLPHENIDATE ER TABLETS Source text for Eikon:",
    "published": "2018-03-22T14:22:00.000+02:00",
    "crawled": "2018-03-22T14:34:06.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "canada",
        "announces",
        "launch",
        "generic",
        "concerta",
        "treatment",
        "adhd",
        "reuters",
        "staff",
        "march",
        "reuters",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "act",
        "methylphenidate",
        "tablet",
        "generic",
        "version",
        "treatment",
        "adhd",
        "teva",
        "canada",
        "limited",
        "say",
        "health",
        "canada",
        "approved",
        "application",
        "c",
        "act",
        "methylphenidate",
        "er",
        "tablet",
        "source",
        "text",
        "eikon"
    ]
}